******** * ** ***

***** ** *** ********* is *** usually ** *** ** **************

*** ******** *** health ****** ** *** ***********

*** fund new public ****** programs

CTo ******* *** etiology ** disease

*** ******* *** occurrence ** ********

ETo ******* *** ************ of disease

******** * ** 25

*** ******** Intelligence ******* ***** is *********** for ***** *** **** answer):

Atracking **** ******* ******* ********* ** *** ****** ****** *** ******* **********

Bcollecting ************* ************ *** ***** health departments

************** epidemiologic *********** ** ******* ** *** **********

********** ********** epidemiologic ****** ** governmental *********

******** * of ***

***** ** *** ********* ********** ************* * ******** approach *** opposed ** ** epidemiologic ***********

************ ** ******** ***** *** symptoms

************ ** ******** trends ** disease occurrence

************ ** disease occurrence ***** population *******

************** ** ********** ********** ** ******* **********

******** * ** ***

Indicate *** level of ********** represented ** ********* *** breast *******

******** Prevention *******

BPrimary ********** ********

********** ***********

********* ***********

Question * of ***

****** ********** in *** ********** ** ********* *** ********* mortality *** ********

********* ********** ** ***** of **********

Bthe **** **** ********* ** * disappearing disorder

********** ******* ** ********* trends

Dboth * and **

******** * ** ***

***** of the following terms ** ********* ** * ********** *** ************* **** a ********

***** ****** * ****** Births

BFemale ****** / **** * ****** *******

******* ****** * Male *******

** *** **

Question 7 of 25

*** risk ** ********* * ***** ******* during * **** period ** **** ********** by

**** mortality **** **** **** disease ** *** *** *** ******

** **** *** **** ******* all ***** ** *** disease in the **** *****

**** ****** prevalence for that ******* ****** *** past *****

Dthe incidence rate (cumulative incidence) *** **** disease ** a ***** ****** of *****

Question 8 ** ***

** ************* ****** of ************** ********* ** Metroville * **** with * ********** of ****** produced *** ***********

****** ** skaters ** Metroville ****** *** given month: ******

************** ********* ** *********** ****

***** number ** ********* ******* **** roller-skating:1800

Total ****** ** ****** **** ******************

***** ****** ** deaths from all causes:900

*** cause-specific mortality **** **** ************** *****

******* ******* *******

********** × *******

C90/1800 ******* *******

******* ******* *******

******** 9 ** 25

The *** ** ********** *********** ******* *** ** thought of as following *** ******** of

AGraunt

BSnow

******

DSemmelweis

******** 10 ** ***

** * ************** of ******* age ** perhaps *** **** ********* ****** to ******** **** *** ** ********** the ********** ** ********* any disease or ******* ********

****** ****** *** **** ****** **********

****** people seek ******* treatment **** ******

****** is * ******* ******** ** age-specific ******* ***** **** in ***** defined by ****** *** other ******** **********

****** are **** ******* in ages than ** ************ ****** ** ******** ** * ***********

******** ** ** ***

**** ******* ****** ** ********** in ********* ********* ******* ** ******* ********* over ******

******** in ********** *********

BChanges in the *** distribution

******** in *** fatal ****** ** *** **********

DAll ** the above

******** ** ** ***

********* to *** ******* history ** ******* ***** the **** ****** *** ********** ** ******* and *** host ******** ** ****** *** ****** ***

APrepathogenesis

**************

**************

DB *** **

******** ** ** ***

***** **** ** ********** ***** ***** after *** ********** ** ******* ******** **** *** ******

ATertiary

***********

*********

***** A and B

******** 14 ** ***

In 1900 the ***** **** per 100000 population *** ********* *** ********* (I & ** *** ***** it *** 224 ** **** *** **** did the death rate *** ** * & * decline

*****

*******

*****

D9%

***** of the above

******** ** of 25

Blood ******** ************ on ***** ***** 30-39 ***** ** *** were ******** in a ****** ** * ************** ****** ** **** ****** ********** ** ******* *** frequency ** ************ ** the white *** ********* population surveyed *** **** appropriate ******* ** ****

********** rate

Bprevalence

Crace-specific ***********

************** incidence *****

***** **********

Question ** ** 25

Incidence *** ********** **** **** ********* applications in ****** ****** ********** **** ** used:

**** estimating *** ********* ** *********

*** ******* the ****** ** extent ** **** ********* ** ********* in * population

CTo ******* a ****** ******** ** the **** of ********** * ********

DA *** **

******** ** ** ***

The ********* ** * ******* ** **** ***** ******* in *** **** in women *** the prevalence shows ** *** ********** The **** ****** *********** ** that:

Athe ********* rate ** ******* ** ******

Bthe **** ******** **** ** ******* ** women

**** ******** ** *** ******* ** ******* ** women

Dwomen ******* **** ******** ******* **** for the ********

******** 18 ** ***

High ***** ** mortality **** hypertension ***** ***** ******* ********* *** be *** to

ADietary ********

********* ** stress

CObesity

**** ** *** above

Question ** ** ***

********* ** classic ******* age-standardized ********* rates ** the ****** ****** *** acute ********** chronic ********** and ********** *** ** ***** ********** **** *** ********* sex *************

****** for ***** *** higher **** rates *** females

****** *** males *** ***** ** *** ***** *** females

****** for ******* are ****** **** rates *** ******

DFemales **** higher ***** of hearing ********** **** ******

** *** **

******** ** ** ***

*********** epidemiology ************* the amount *** ************ ** disease ****** a population to ****** *** ********** to

***** ****** tests ** ********* hypotheses

********* ******** hypotheses ********* *********

Cevaluate ****** ** health *** ******* ****** * ***********

DAll ** *** ******

EB *** * only

******** ** ** 25

******* of nativity *** ********* have reported ******

********** rates of ************ ******* to ****** ********* **** ***** than for native-born persons

********* found ** less ********* ******* are ** ****** * ******* in *** ****** *******

***** migrants **** inadequate ************ status **** ******* ** ******************* diseases

************* ******** ** ********** ********* have **** ****** ***********

******** 22 of 25

******** *** ********* ****** Case ************

*** of ************* ************ *** **** diseases ******* ******** *** occur ** ****** alone

********* ****** ******** ** a ***** ** ****** ** ** ********* agent

*** called ******** ********** *** geographic ************** of ******

**** **** ***** *** ************ *** ******* **********

***** ** ***** are correct

******** ** ** ***

Which ** *** ********* reasons might ******* *** ***** ********* ** disease

************** ** racial or ethnic groups within ** *****

BGenetic *** *********** interactions

********** ** climate

DPresence ** ************* ************

**** ** the ******

Question ** ** ***

Which ** Mill’s **** ****** ******** **** ***** is ** *********** ******* ********* of ******* *** *** ******* ** * ********* factor

************

***********

************ **********

**********

******** 25 of ***

***** ************ *** operational ******** involves:

****** ** ********* ****** *********

****** ** ***** to *** ***********

Cstudy ** disease **********

**** ** the *****

Click here to download attached files:
HSA 535 MIDTERM LATEST 2016.docx